Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Lysosomal Protein Transmembrane 4 beta (LAPTM4B) (Middle Region) Peptid

LAPTM4B Wirt: Synthetic BP, WB, IHC
Produktnummer ABIN8104700
168,15 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 6 bis 9 Werktagen

Kurzübersicht für Lysosomal Protein Transmembrane 4 beta (LAPTM4B) (Middle Region) Peptid (ABIN8104700)

Target

LAPTM4B (Lysosomal Protein Transmembrane 4 beta (LAPTM4B))

Quelle

  • 4
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
  • Protein Region

    Middle Region

    Verwendungszweck

    LAPTM4B Peptide - middle region
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Kommentare

    This is a synthetic peptide designed for use in combination with anti-LAPTM4B antibody ( ARP47442_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Buffer

    Lyophilized powder

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
  • Target

    LAPTM4B (Lysosomal Protein Transmembrane 4 beta (LAPTM4B))

    Hintergrund

    Background Information: LAPTM4B is a multi-pass membrane protein. It belongs to the LAPTM4/LAPTM5 transporter family. LAPTM4b has active role in disease progression of malignant cells and is involved in cell proliferation and multidrug resistance. The genetic polymorphism of LAPTM4B is a potential risk factor for the development of colon cancer and gastric cancer. The research results also indicated that LAPTM4B may be a clinically useful prognostic indicator for ovarian carcinoma and may play a role in human hepatocellular carcinoma.

    Alternative Symbols: LAPTM4beta, LC27

    Molekulargewicht

    35kDa

    Gen-ID

    55353

    NCBI Accession

    NP_060877

    UniProt

    Q86VI4
Sie sind hier:
Chat with us!